The Cancer Genome Atlas Program (TCGA) analysis reveals high frequency of BRG1 overexpression, but low frequency of BRG1 mutation, in invasive breast cancer [39, 40]. This evidence concerns the gene SMARCA4 and invasive breast carcinoma.